New York, NY, United States of America

Lior Zangi

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Brookline, MA (US) (2018)
  • New York, NY (US) (2022)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Lior Zangi: Innovator in RNA Technology

Introduction

Lior Zangi is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of RNA technology. He holds a total of 4 patents, showcasing his innovative approach to gene expression modulation.

Latest Patents

Zangi's latest patents include groundbreaking work on efficient protein expression in vivo using modified RNA (mod-RNA). This invention focuses on synthetic, modified RNAs and their application in vivo to modulate gene expression, particularly in myocytes, cardiomyocytes, and tumors. Another notable patent is the development of a cell-specific expression regulatory system. This system enables the transcription of a protein of interest in a cell-specific manner, which can reactivate proliferation in adult or neonatal cardiomyocytes or insulin-producing beta cells.

Career Highlights

Throughout his career, Lior Zangi has worked with esteemed institutions such as the Icahn School of Medicine at Mount Sinai and The General Hospital Corporation. His work has significantly advanced the understanding of RNA technology and its applications in medicine.

Collaborations

Zangi has collaborated with notable colleagues, including Ajit Magadum and Kenneth R. Chien, further enhancing the impact of his research and innovations.

Conclusion

Lior Zangi's contributions to RNA technology and gene expression modulation have established him as a leading inventor in his field. His innovative patents and collaborations continue to influence advancements in medical research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…